Open Interest and Volume Dynamics
On 24 Jul 2026, Lupin Ltd. (symbol: LUPIN) recorded an open interest (OI) of 27,212 contracts in its derivatives, up from 24,718 contracts the previous day. This represents a robust increase of 2,494 contracts or 10.09%, indicating a fresh influx of positions in the futures and options market. The volume for the day stood at 21,095 contracts, underscoring active trading interest.
The futures segment alone accounted for a value of approximately ₹85,520 lakhs, while the options segment exhibited a significantly larger notional value of ₹12,991.27 crores. The combined derivatives turnover thus reached ₹86,672 lakhs, reflecting substantial liquidity and investor engagement.
Price Performance and Moving Averages
Despite the surge in derivatives activity, Lupin’s underlying equity price has been under pressure. The stock has declined for three consecutive sessions, losing 5.88% over this period. On 24 Jul, it closed down 1.44% at ₹2,369, underperforming its sector by 0.6% and the broader Sensex by 1.03%. Intraday, the stock touched a low of ₹2,340, down 2.35% from the previous close.
Technically, Lupin’s price remains above its 50-day, 100-day, and 200-day moving averages, signalling a longer-term uptrend. However, it is trading below its 5-day and 20-day moving averages, indicating short-term weakness and potential consolidation or correction.
Investor Participation and Liquidity Considerations
Investor participation appears to be waning, with delivery volumes on 23 Jul falling sharply by 34.69% to 3.72 lakh shares compared to the five-day average. This decline in delivery volume suggests reduced conviction among long-term holders or profit-booking by investors. Nevertheless, the stock remains sufficiently liquid, with a trading capacity of ₹4.2 crores based on 2% of the five-day average traded value, allowing for sizeable trades without significant market impact.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Market Positioning and Potential Directional Bets
The sharp rise in open interest amid a falling stock price suggests that new positions are being established, possibly reflecting a mix of hedging and speculative strategies. The increase in OI alongside declining prices often points to fresh short positions or put buying, indicating bearish sentiment among derivatives traders. However, the sizeable options notional value hints at active call option writing or buying as well, which could signal hedging against a potential rebound or volatility plays.
Given Lupin’s strong fundamentals and a recent upgrade in its Mojo Grade from Buy to Strong Buy on 21 Jul 2026, with a high Mojo Score of 84.0, some investors may be positioning for a medium-term recovery despite near-term weakness. The stock’s mid-cap status and ₹1,07,989.18 crore market capitalisation further attract institutional interest, which often manifests in derivatives activity ahead of anticipated corporate developments or sectoral catalysts.
Sector and Broader Market Context
Lupin operates within the Pharmaceuticals & Biotechnology sector, which has shown mixed performance recently. The sector’s 1-day return of -0.51% and the Sensex’s -0.41% return on 24 Jul 2026 reflect a cautious market environment. Lupin’s underperformance relative to both benchmarks highlights stock-specific pressures, possibly linked to profit-taking or concerns over near-term earnings visibility.
Nonetheless, Lupin’s price remaining above key long-term moving averages suggests that the broader uptrend remains intact, and the recent open interest surge could be a precursor to a directional shift once market participants digest upcoming earnings or regulatory updates.
Curious about Lupin Ltd. from Pharmaceuticals & Biotechnology? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!
- - Detailed research coverage
- - Technical + fundamental view
- - Decision-ready insights
Implications for Investors
For investors, the current derivatives activity in Lupin Ltd. signals a complex interplay of bullish and bearish forces. The strong Mojo Grade upgrade to Strong Buy reflects confidence in the company’s fundamentals and growth prospects. However, the recent price weakness and falling delivery volumes caution against aggressive long positions in the short term.
Active traders may find opportunities in the options market, where increased open interest and volume suggest heightened volatility and potential for directional bets. Meanwhile, long-term investors should monitor Lupin’s price action relative to its moving averages and sector trends, as well as upcoming earnings releases and regulatory developments that could influence sentiment.
Overall, Lupin’s derivatives market behaviour underscores the importance of combining technical signals with fundamental analysis to navigate the evolving landscape of mid-cap pharmaceutical stocks.
Summary
Lupin Ltd. has experienced a significant 10.1% rise in open interest in its derivatives segment, reflecting increased market participation amid a three-day price decline. While the stock remains above key long-term moving averages, short-term technicals indicate weakness. The mixed signals from derivatives activity suggest both bearish positioning and hedging for potential rebounds. With a recent Mojo Grade upgrade to Strong Buy and a robust market cap of ₹1,07,989.18 crore, Lupin remains a stock to watch closely for directional cues and investment opportunities.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
